WallStreetZenWallStreetZen

NASDAQ: YTEN
Yield10 Bioscience Inc Stock

$2.50-0.16 (-6.02%)
Updated Mar 24, 2023
YTEN Price
$2.50
Fair Value Price
$2.98
Market Cap
$12.69M
52 Week Low
$1.63
52 Week High
$6.12
P/E
-0.91x
P/B
2.88x
P/S
18.23x
PEG
N/A
Dividend Yield
N/A
Revenue
$450.00k
Earnings
-$13.57M
Gross Margin
100%
Operating Margin
-2,980%
Profit Margin
-3,014.7%
Debt to Equity
0.84
Operating Cash Flow
-$11M
Beta
0.9
Next Earnings
May 9, 2023
Ex-Dividend
N/A
Next Dividend
N/A

YTEN Overview

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.

Zen Score

Industry Average (35)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how YTEN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

YTEN ($2.50) is undervalued by 16.01% relative to our estimate of its Fair Value price of $2.98 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
YTEN ($2.50) is not significantly undervalued (16.01%) relative to our estimate of its Fair Value price of $2.98 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
YTEN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more YTEN due diligence checks available for Premium users.

Be the first to know about important YTEN news, forecast changes, insider trades & much more!

YTEN News

Valuation

YTEN fair value

Fair Value of YTEN stock based on Discounted Cash Flow (DCF)
Price
$2.50
Fair Value
$2.98
Undervalued by
16.01%
YTEN ($2.50) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
YTEN ($2.50) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
YTEN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

YTEN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.91x
Industry
15.23x
Market
21.37x

YTEN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.88x
Industry
1.7x
YTEN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

YTEN's financial health

Profit margin

Revenue
$87.0k
Net Income
-$3.3M
Profit Margin
-3,796.6%
YTEN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
YTEN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$8.1M
Liabilities
$3.7M
Debt to equity
0.84
YTEN's short-term assets ($5.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
YTEN's short-term assets ($5.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
YTEN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
YTEN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.1M
Investing
$1.5M
Financing
$0.0
YTEN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

YTEN vs Agricultural Input Stocks

TickerMarket Cap1d %P/EP/B
YTEN$12.69M-6.09%-0.91x2.88x
RKDA$4.60M+1.77%-0.20x0.18x
SVFD$3.38M+1.78%-0.38x0.48x
SEED$37.32M-2.35%-38.46x-1.88x
CGA$55.40M+1.72%-0.78x0.39x

Yield10 Bioscience Stock FAQ

What is Yield10 Bioscience's quote symbol?

NASDAQ: YTEN) Yield10 Bioscience trades on the NASDAQ under the ticker symbol YTEN. Yield10 Bioscience stock quotes can also be displayed as NASDAQ: YTEN.

If you're new to stock investing, here's how to buy Yield10 Bioscience stock.

What is the 52 week high and low for Yield10 Bioscience (NASDAQ: YTEN)?

(NASDAQ: YTEN) Yield10 Bioscience's 52-week high was $6.12, and its 52-week low was $1.63. It is currently -59.15% from its 52-week high and 53.37% from its 52-week low.

How much is Yield10 Bioscience stock worth today?

(NASDAQ: YTEN) Yield10 Bioscience currently has 5,074,085 outstanding shares. With Yield10 Bioscience stock trading at $2.50 per share, the total value of Yield10 Bioscience stock (market capitalization) is $12.69M.

Yield10 Bioscience stock was originally listed at a price of $37,248.00 in Nov 10, 2006. If you had invested in Yield10 Bioscience stock at $37,248.00, your return over the last 16 years would have been -99.99%, for an annualized return of -45.15% (not including any dividends or dividend reinvestments).

How much is Yield10 Bioscience's stock price per share?

(NASDAQ: YTEN) Yield10 Bioscience stock price per share is $2.50 today (as of Mar 24, 2023).

What is Yield10 Bioscience's Market Cap?

(NASDAQ: YTEN) Yield10 Bioscience's market cap is $12.69M, as of Mar 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Yield10 Bioscience's market cap is calculated by multiplying YTEN's current stock price of $2.50 by YTEN's total outstanding shares of 5,074,085.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.